Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus.
Mater Adv
; 5(4): 1473-1479, 2024 Feb 19.
Article
en En
| MEDLINE
| ID: mdl-38380336
ABSTRACT
We have developed nanoparticle formulations targeting M2 macrophages for cancer immunotherapy by conjugating high-affinity binding peptides to cowpea mosaic virus as an immunostimulatory adjuvant. We confirmed the targeting of and uptake by M2 macrophages in vitro and the therapeutic efficacy of the nanoparticles against murine melanoma in vivo.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Mater Adv
Año:
2024
Tipo del documento:
Article